CWANInformation Technology·Sep 3, 2026·12 min read

CWAN Clearwater Analytics Thesis 2026: Cloud Investment Accounting SaaS Drives Enfusion Beacon Platform Expansion

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) FY2026 thesis centers on continued Core Investment Accounting SaaS Platform pipeline (~$0.55-0.65B revenue) + Enfusion + Beacon + International Platform Expansion pipeline (~$0.25-0.35B aggregate FY2026 revenue) under continued President + CEO Sandeep Sahai since 2019 (~6-year tenure as Clearwater Analytics CEO; selected primary architect of post-2019 cloud SaaS platform transformation + post-September 2021 NYSE IPO + post-November 2024 ~$1.5B aggregate Enfusion acquisition + post-2025 ~$0.66B aggregate Beacon Platform + Bistro acquisitions). FY2025 revenue ~$0.80-0.90B (+30-45% YoY) with adj. EPS ~$0.50-0.65 reflecting continued ~$7.5-8.5T aggregate AUA on platform + selected primary post-September 2021 IPO + post-2024-2025 transformative Enfusion + Beacon acquisitions adding ~$200-260M aggregate revenue. CWAN operates as 1 primary segment (cloud-based investment accounting + reporting + analytics SaaS) with revenue structure Core Clearwater ~70-75% ($0.55-0.65B) + Enfusion ~22-26% ($0.18-0.22B post-November 2024) + Beacon Platform + Bistro ~5-9% ($0.05-0.08B post-2025) and geographic mix North America ~80-85% + EMEA ~10-15% + APAC ~3-5%. Customer mix: ~52% US Insurance + ~22% Asset Managers + ~12% Corporate Treasuries + ~14% Pension + Endowment + Government. Core Investment Accounting SaaS Platform pipeline (~$0.55-0.65B revenue + ~70-75% revenue mix): ~110% aggregate gross retention + ~115-120% aggregate net revenue retention top-quartile vs vertical SaaS peer median ~108-115% + ~$7.5-8.5T aggregate AUA on platform + ~1,500+ aggregate clients (US Insurance + Asset Managers + Corporate Treasuries + Pension + Endowment + Government customer base) + multi-tenant cloud-based single-platform single-database architecture (differentiated vs legacy SS&C Advent + Eze + FIS + BlackRock Aladdin point-solution legacy systems). Enfusion + Beacon + International Platform Expansion pipeline: post-November 2024 ~$1.5B aggregate Enfusion acquisition (cloud-based hedge fund + asset manager Order Management System + Investment Book of Record + ~$0.18-0.22B FY2025 annualized revenue + ~$1.0T+ Enfusion AUM) + post-2025 ~$0.66B aggregate Beacon Platform + Bistro acquisitions (risk + analytics + portfolio management + position-keeping platform expansion + ~$0.05-0.08B FY2025 annualized revenue) + International + EMEA + APAC expansion + Insurance + Asset Manager + Hedge Fund + Corporate Treasury cross-sell pipeline. Capital position + balance sheet: no dividend (capital reinvestment + acquisition priority) + ~$25-100M aggregate FY2025 buybacks + aggregate capital return ~$25-100M FY2025 + aggregate cash + investments ~$0.30-0.45B + ~$0.6-0.8B aggregate gross debt + net leverage ~1.5-2.5x Net Debt/Adj. EBITDA + non-investment-grade credit profile + ~250-260M aggregate diluted shares. FY2026 base case ~$1.00-1.15B aggregate revenue + ~$0.60-0.80 adj. EPS + ~$50-150M aggregate capital return; bull case Core Investment Accounting SaaS Platform pipeline acceleration (~$8.5-9.5T aggregate FY2026 AUA + ~120-125% aggregate net revenue retention + ~1,700+ aggregate FY2026 client base) + Enfusion + Beacon + International Platform Expansion pipeline acceleration (post-November 2024 Enfusion ~$75-100M FY2026 cost synergies realization + post-2025 Beacon + Bistro integration synergies + International + EMEA + APAC expansion) drives ~$1.10-1.25B aggregate revenue + ~$0.75-0.95 EPS; bear case SS&C Technologies + FIS + BlackRock Aladdin + Bloomberg AIM + State Street Alpha + Charles River + FactSet + MSCI + Morningstar + Envestnet competitive intensification + post-November 2024 Enfusion integration execution delays + post-2025 Beacon + Bistro integration delays + net revenue retention deceleration + International + EMEA + APAC expansion considerations + post-2019 Sandeep Sahai CEO succession planning considerations drives ~$0.90-1.00B revenue + ~$0.40-0.55 EPS.

[CWAN] Clearwater Analytics Thesis 2026: Cloud Investment Accounting SaaS Drives Enfusion Beacon Platform Expansion

Key Takeaways

  • CWAN FY2025 revenue ~$0.80-0.90B (+30-45% YoY) with adj. EPS ~$0.50-0.65 reflecting continued ~$7.5-8.5T aggregate assets-under-administration on platform + selected primary post-September 2021 IPO + post-2024-2025 transformative Enfusion + Beacon acquisitions adding ~$200-260M aggregate revenue under continued President + CEO Sandeep Sahai since 2019 (~6-year tenure as Clearwater Analytics CEO; selected post-2019 succession from founder David Boren retirement; selected primary architect of post-2019 cloud-based SaaS platform transformation + post-September 2021 NYSE IPO + selected primary architect of post-November 2024 ~$1.5B aggregate Enfusion acquisition + post-2025 ~$0.66B aggregate Beacon Platform + Bistro acquisitions).
  • Core Investment Accounting SaaS Platform Pipeline (~$0.55-0.65B Revenue): ~$0.55-0.65B aggregate Core Clearwater Investment Accounting SaaS revenue (~70-75% revenue mix excluding Enfusion + Beacon; ~110% aggregate gross retention + ~115-120% aggregate net revenue retention top-quartile vs vertical SaaS peer median ~108-115%); selected primary ~$7.5-8.5T aggregate assets-under-administration on platform + selected various aggregate ~1,500+ aggregate clients (~52% aggregate US Insurance + ~22% aggregate Asset Managers + ~12% aggregate Corporate Treasuries + ~14% aggregate Pension + Endowment + selected various aggregate Government); selected primary multi-tenant cloud-based single-platform single-database architecture (selected primary differentiated vs legacy SS&C Advent + Eze + selected various aggregate FIS + BlackRock Aladdin point-solution legacy systems).
  • Enfusion + Beacon + International Platform Expansion Pipeline (~$0.20-0.26B Revenue + Strategic Catalyst): post-November 2024 ~$1.5B aggregate Enfusion acquisition (selected primary cloud-based hedge fund + asset manager Order Management System + Investment Book of Record + selected various aggregate ~$0.18-0.22B aggregate Enfusion FY2025 annualized revenue + ~$1.0T+ aggregate Enfusion AUM) + selected various aggregate post-2025 ~$0.66B aggregate Beacon Platform + Bistro acquisitions (selected primary risk + analytics + portfolio management + position-keeping platform expansion; selected various aggregate ~$0.05-0.08B aggregate Beacon FY2025 annualized revenue) + selected various aggregate International + EMEA + APAC expansion + selected various aggregate Insurance + Asset Manager + Hedge Fund + Corporate Treasury cross-sell pipeline.
  • Capital position + balance sheet: no dividend (capital reinvestment + acquisition priority); ~$25-100M aggregate FY2025 buybacks; aggregate capital return ~$25-100M FY2025; aggregate cash + investments ~$0.30-0.45B post-November 2024 Enfusion + post-2025 Beacon + Bistro acquisitions; ~$0.6-0.8B aggregate gross debt + ~$0.3-0.5B aggregate net debt (post-November 2024 Enfusion + post-2025 Beacon debt financing); net leverage ~1.5-2.5x Net Debt/Adj. EBITDA; non-investment-grade credit profile; ~250-260M aggregate diluted shares.
  • FY2026 thesis catalysts: Core Investment Accounting SaaS Platform pipeline (~$0.55-0.65B + ~110% gross retention + ~115-120% net revenue retention + $7.5-8.5T aggregate AUA) + Enfusion + Beacon + International Platform Expansion pipeline ($0.25-0.35B aggregate FY2026 Enfusion + Beacon revenue + post-November 2024 Enfusion integration + post-2025 Beacon + Bistro integration synergies + International expansion) + ~115-120% aggregate net revenue retention top-quartile + Sandeep Sahai strategic platform expansion execution.

Company Background

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) is a US cloud-based investment accounting + reporting + analytics SaaS platform provider, founded 2004 in Boise Idaho by David Boren (21-year operating history; selected primary post-2004 founding as cloud-based investment accounting alternative to legacy on-premise SS&C Advent + Eze + selected various aggregate FIS systems). Selected post-September 2021 NYSE IPO ($540M aggregate at-IPO capital raise + selected various aggregate Welsh Carson + Permira + Warburg Pincus pre-IPO PE sponsor backing); selected post-2019 Sandeep Sahai CEO appointment + selected primary architect of post-2019 cloud SaaS platform transformation + multi-tenant single-database architecture expansion; selected post-November 2024 ~$1.5B aggregate Enfusion acquisition (selected primary cloud-based hedge fund + asset manager OMS/IBOR); selected post-2025 ~$0.66B aggregate Beacon Platform + Bistro acquisitions (selected primary risk + analytics + portfolio management + position-keeping platform); HQ Boise Idaho; ~3,400-3,800 employees globally.

CWAN operates as 1 primary segment (cloud-based investment accounting + reporting + analytics SaaS). Revenue ~$0.80-0.90B aggregate; selected primary Core Clearwater Investment Accounting SaaS revenue 70-75% ($0.55-0.65B) + Enfusion 22-26% ($0.18-0.22B aggregate annualized post-November 2024 acquisition) + Beacon Platform + Bistro 5-9% ($0.05-0.08B aggregate annualized post-2025 acquisitions). Geographic mix: North America ~80-85% + EMEA ~10-15% + APAC ~3-5%. Customer mix: ~52% aggregate US Insurance + ~22% aggregate Asset Managers + ~12% aggregate Corporate Treasuries + ~14% aggregate Pension + Endowment + Government.

Capital position: no dividend; ~$25-100M aggregate FY2025 buybacks; aggregate capital return ~$25-100M FY2025; aggregate cash + investments ~$0.30-0.45B post-acquisitions; net leverage ~1.5-2.5x Net Debt/Adj. EBITDA; non-investment-grade credit profile; ~250-260M aggregate diluted shares.

Core Investment Accounting SaaS Platform Pipeline (~$0.55-0.65B Revenue)

The Core Investment Accounting SaaS Platform pipeline is CWAN's foundation thesis: ~$0.55-0.65B aggregate Core Clearwater Investment Accounting SaaS revenue (~70-75% revenue mix excluding Enfusion + Beacon; ~110% aggregate gross retention + ~115-120% aggregate net revenue retention top-quartile vs vertical SaaS peer median ~108-115%); selected primary ~$7.5-8.5T aggregate assets-under-administration on platform + selected various aggregate ~1,500+ aggregate clients (~52% aggregate US Insurance + ~22% aggregate Asset Managers + ~12% aggregate Corporate Treasuries + ~14% aggregate Pension + Endowment + selected various aggregate Government); selected primary multi-tenant cloud-based single-platform single-database architecture (selected primary differentiated vs legacy SS&C Advent + Eze + selected various aggregate FIS + BlackRock Aladdin point-solution legacy systems).

FY2025 Core Investment Accounting SaaS Platform dynamics ($0.55-0.65B aggregate Core Clearwater revenue): selected continued post-2024 ~+18-25% aggregate Core Clearwater Investment Accounting SaaS revenue growth (selected primary ~115-120% aggregate net revenue retention + selected various aggregate ~$7.5-8.5T aggregate AUA platform expansion + selected various aggregate ~1,500+ aggregate client net new logo growth + selected various aggregate Insurance + Asset Manager + Corporate Treasury cross-sell + selected various aggregate multi-tenant cloud-based architecture differentiation) + ~$0.55-0.65B aggregate Core Clearwater revenue + selected various aggregate ~110% aggregate gross retention + selected various aggregate ~115-120% aggregate net revenue retention. Selected post-2024 ~$0.40-0.50 incremental annual EPS contribution as Core Investment Accounting SaaS Platform pipeline drives incremental recurring SaaS revenue.

FY2026 catalyst: continued Core Investment Accounting SaaS Platform pipeline + ~$0.40-0.50 incremental annual EPS contribution under continued Sandeep Sahai leadership (~6-year tenure). Selected aggregate ~$0.65-0.78B aggregate FY2026 Core Clearwater revenue + selected various ~+18-22% aggregate growth + selected various aggregate ~$8.5-9.5T aggregate FY2026 AUA platform expansion + selected various aggregate ~115-120% aggregate net revenue retention + selected various aggregate ~1,700+ aggregate FY2026 client base + selected various aggregate Insurance + Asset Manager + Corporate Treasury cross-sell. Risks: SS&C Technologies (SSNC, ~$15-18B Mcap; Advent + Eze + selected various aggregate legacy on-premise + cloud investment accounting) + FIS (FIS, ~$30-35B; legacy banking + investment accounting) + BlackRock Aladdin (BLK ~$130-150B Mcap; #1 global front-to-back investment platform) + Bloomberg AIM (Bloomberg L.P.; private; Asset & Investment Manager order management) + State Street Alpha (STT ~$25-30B; investment platform) + Northern Trust Front Office Solutions (NTRS ~$20-25B; Trust + investment accounting) + selected various aggregate Insurance + Asset Manager + Corporate Treasury investment accounting + reporting + analytics competitive considerations + selected various aggregate vertical SaaS competitive considerations + selected various aggregate net revenue retention cycle considerations + selected various aggregate cloud-based investment accounting platform competitive considerations.

Enfusion + Beacon + International Platform Expansion Pipeline (~$0.20-0.26B Revenue + Strategic Catalyst)

The Enfusion + Beacon + International Platform Expansion pipeline is CWAN's primary growth thesis: post-November 2024 ~$1.5B aggregate Enfusion acquisition (selected primary cloud-based hedge fund + asset manager Order Management System + Investment Book of Record + selected various aggregate ~$0.18-0.22B aggregate Enfusion FY2025 annualized revenue + ~$1.0T+ aggregate Enfusion AUM) + selected various aggregate post-2025 ~$0.66B aggregate Beacon Platform + Bistro acquisitions (selected primary risk + analytics + portfolio management + position-keeping platform expansion; selected various aggregate ~$0.05-0.08B aggregate Beacon FY2025 annualized revenue) + selected various aggregate International + EMEA + APAC expansion + selected various aggregate Insurance + Asset Manager + Hedge Fund + Corporate Treasury cross-sell pipeline.

FY2025 Enfusion + Beacon + International dynamics: selected primary post-November 2024 ~$1.5B aggregate Enfusion acquisition integration + selected various aggregate ~$0.18-0.22B aggregate FY2025 Enfusion annualized revenue (~Q4 FY2024-FY2025 first full year combined post-acquisition contribution) + selected primary post-2025 ~$0.66B aggregate Beacon Platform + Bistro acquisitions integration + selected various aggregate ~$0.05-0.08B aggregate FY2025 Beacon annualized revenue + selected various aggregate International + EMEA + APAC platform expansion + selected various aggregate Enfusion Hedge Fund + Asset Manager front-to-back integration with Core Clearwater Investment Accounting platform. Selected post-2024 ~$0.10-0.20 incremental annual EPS contribution as Enfusion + Beacon + International Platform Expansion pipeline drives incremental margin (post-November 2024 Enfusion integration + post-2025 Beacon + Bistro integration synergies).

FY2026 catalyst: continued Enfusion + Beacon + International Platform Expansion pipeline + ~$0.10-0.20 incremental EPS contribution. Selected aggregate ~$0.25-0.35B aggregate FY2026 combined Enfusion + Beacon + Bistro revenue + selected various aggregate ~+15-25% aggregate FY2026 Enfusion + Beacon + Bistro growth + selected various aggregate post-November 2024 Enfusion ~$50-75M aggregate FY2026 cost synergies realization + selected various aggregate post-2025 Beacon + Bistro integration synergies + selected various aggregate International + EMEA + APAC expansion + selected various aggregate Insurance + Asset Manager + Hedge Fund + Corporate Treasury cross-sell + selected various aggregate Investment Book of Record + Order Management + Risk Analytics + Portfolio Management end-to-end platform expansion. Risks: SS&C Eze + Advent + BlackRock eFront + Aladdin (selected primary post-2021 eFront integration) + Charles River Development (State Street; Charles River acquired 2018) + Bloomberg AIM + LPL Financial + Envestnet + FactSet + Refinitiv Workspace + Moody's Bureau van Dijk + selected various aggregate Hedge Fund + Asset Manager front-to-back competitive considerations + selected various aggregate Risk Analytics + Portfolio Management competitive considerations + selected various aggregate post-November 2024 Enfusion integration execution considerations + selected various aggregate post-2025 Beacon + Bistro integration considerations + selected various aggregate International + EMEA + APAC expansion considerations.

Capital Position + Balance Sheet

Capital position + balance sheet: no dividend (capital reinvestment + acquisition priority) + ~$25-100M aggregate FY2025 buybacks + aggregate capital return ~$25-100M FY2025 + aggregate cash + investments ~$0.30-0.45B post-November 2024 Enfusion + post-2025 Beacon + Bistro acquisitions + ~$0.6-0.8B aggregate gross debt + ~$0.3-0.5B aggregate net debt + net leverage ~1.5-2.5x Net Debt/Adj. EBITDA + non-investment-grade credit profile + ~250-260M aggregate diluted shares + weighted average debt maturity ~4-5 years.

FY2026 catalyst: continued ~$50-150M aggregate annual capital return + selected continued no dividend policy + selected continued ~$25-100M aggregate annual buybacks + selected continued ~1.5-2.5x net leverage (post-November 2024 Enfusion + post-2025 Beacon + Bistro deleveraging glide path) + selected continued non-investment-grade credit profile. Selected post-November 2024 + post-2025 acquisitions transformative platform expansion period + selected continued ~1.5-2.5x net leverage discipline + selected various aggregate ~$50-150M aggregate FY2026 buyback capacity support continued Core Clearwater + Enfusion + Beacon + International platform expansion.

Key Core Metrics

  • FY2025 revenue ~$0.80-0.90B (+30-45% YoY) vs $0.62B FY2024; adj. EPS ~$0.50-0.65
  • 1 primary segment: cloud-based investment accounting + reporting + analytics SaaS ~100%
  • Structure: Core Clearwater Investment Accounting SaaS ~70-75% ($0.55-0.65B) + Enfusion ~22-26% ($0.18-0.22B) + Beacon Platform + Bistro ~5-9% ($0.05-0.08B)
  • Geographic mix: North America ~80-85% + EMEA ~10-15% + APAC ~3-5%
  • Customer mix: ~52% US Insurance + ~22% Asset Managers + ~12% Corporate Treasuries + ~14% Pension + Endowment + Government
  • Assets-under-administration on platform: ~$7.5-8.5T aggregate FY2025 (Core Clearwater)
  • Client count: ~1,500+ aggregate FY2025
  • Gross retention: ~110% aggregate (top-quartile)
  • Net revenue retention: ~115-120% aggregate (top-quartile)
  • Multi-tenant cloud-based single-database architecture
  • post-November 2024 Enfusion acquisition: ~$1.5B aggregate (cloud-based hedge fund + asset manager OMS/IBOR + ~$1.0T+ aggregate Enfusion AUM)
  • post-2025 Beacon Platform + Bistro acquisitions: ~$0.66B aggregate (risk + analytics + portfolio management + position-keeping platform)
  • Net leverage ~1.5-2.5x Net Debt/Adj. EBITDA
  • ~250-260M aggregate diluted shares; ~$25-100M total capital return FY2025
  • No dividend (capital reinvestment priority)
  • ~$25-100M aggregate FY2025 buybacks
  • Non-investment-grade credit profile
  • ~3,400-3,800 employees globally
  • Sandeep Sahai CEO since 2019 (~6-year tenure)
  • HQ Boise Idaho
  • Founded 2004 by David Boren

Market Evaluation

CWAN FY2026 market evaluation: at ~$22-32 share price + ~250-260M aggregate diluted shares = ~$5.5-8.5B market cap; no dividend + ~$25-100M aggregate annual buyback capacity. Selected primary CWAN peers: SS&C Technologies (SSNC, ~$15-18B Mcap; Advent + Eze + legacy + cloud investment accounting) + FIS (FIS, ~$30-35B; legacy banking + investment accounting) + Tradeweb Markets (TW, ~$30-35B; Fixed Income electronic trading platform) + MarketAxess (MKTX, ~$8-10B; Fixed Income electronic trading) + FactSet Research Systems (FDS, ~$15-18B; financial data + analytics SaaS) + MSCI (MSCI, ~$45-55B; index + risk analytics) + Morningstar (MORN, ~$13-15B; investment data + research) + Envestnet (ENV, ~$3-5B; Wealth Management platform) + Allvue Systems (private; Investment Management platform) + Eze Software (SS&C Technologies subsidiary; Investment Management platform) + Charles River Development (State Street; Investment Management platform) + Bloomberg AIM (private; Investment Management) + selected various aggregate cloud-based vertical SaaS + Investment Management platform companies. Selected CWAN ~30-45x P/E (premium cloud-based vertical SaaS with ~115-120% net revenue retention + ~$7.5-8.5T aggregate AUA + post-November 2024 Enfusion + post-2025 Beacon + Bistro platform transformation) + selected ~12-18x P/Sales + selected ~25-35x EV/Adj. EBITDA + no dividend + selected aggregate ~$1.00-1.15B aggregate FY2026 revenue + selected aggregate ~$0.60-0.80 aggregate FY2026 EPS + selected aggregate ~$50-150M aggregate FY2026 buyback capacity + selected aggregate Core Investment Accounting SaaS Platform + Enfusion + Beacon + International Platform Expansion pipeline. FY2026 base case: ~$1.00-1.15B aggregate revenue + ~$0.60-0.80 adj. EPS + $50-150M aggregate capital return. Bull case: Core Investment Accounting SaaS Platform pipeline acceleration ($8.5-9.5T aggregate FY2026 AUA + ~120-125% aggregate net revenue retention + ~1,700+ aggregate FY2026 client base) + Enfusion + Beacon + International Platform Expansion pipeline acceleration (post-November 2024 Enfusion ~$75-100M FY2026 cost synergies realization + post-2025 Beacon + Bistro integration synergies + International + EMEA + APAC expansion + Hedge Fund + Asset Manager + Corporate Treasury cross-sell) drives ~$1.10-1.25B aggregate revenue + ~$0.75-0.95 EPS. Bear case: SS&C Technologies + FIS + BlackRock Aladdin + Bloomberg AIM + State Street Alpha + Charles River Development + FactSet + MSCI + Morningstar + Envestnet competitive intensification + post-November 2024 Enfusion integration execution delays + post-2025 Beacon + Bistro integration delays + net revenue retention deceleration (~108-112% aggregate) + cloud-based investment accounting platform competitive intensification + International + EMEA + APAC expansion considerations + post-2019 Sandeep Sahai CEO succession planning considerations drives ~$0.90-1.00B revenue + ~$0.40-0.55 EPS. The thesis depends on Core Investment Accounting SaaS Platform + Enfusion + Beacon + International Platform Expansion + ~115-120% aggregate net revenue retention top-quartile + post-November 2024 Enfusion + post-2025 Beacon + Bistro transformative platform expansion + Sandeep Sahai strategic execution.

Related:CWAN

Want deeper analysis?

Ask drillr anything about CWAN — powered by SEC filings, earnings calls, and real-time data.

Try drillr.ai for free